Introduction. Platelets drive endothelial cell activation in many diseases. 24 However, if this occurs in Plasmodium vivax malaria is unclear. As platelets have 25 been reported to be activated and to play a role in inflammatory response during 26 malaria, we hypothesized that this would correlate with endothelial alterations 27 during acute illness.
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AUTHOR SUMMARY 49 Endothelial cell activation is a key process in the pathogenesis of 50 Plasmodium vivax malaria. Platelets are classically involved endothelial cell 51 activation in several diseases, but their role in context of vivax malaria remains 52 unclear. Thrombocytopenia is the most common hematological disturbance in P. 53 vivax-infected patients, and platelets have been implicated in parasitemia control. 54 In this study, we studied the activation of platelets in association with endothelial 55 cell activation in vivax malaria. Platelets retrieved from infected peripheral blood 56 were non-activated when analyzed by flow cytometry; however, they displayed 57 higher mean volume and significantly reduced counts. We also found higher levels 58 of circulating factors associated with platelet activation (especially CD40L), 59 thrombopoiesis and endothelial cell activation in infected patients. Further, 60 through pair-wise correlation and clustering analysis, we found a subgroup of 61 patients showing significant associations between markers of platelet and 62 endothelial activation in a pattern different from that of endemic controls. 63 Collectively, our findings point to a peculiar role of platelets in endothelial cell 64 activation in vivax malaria and indicate a heterogeneous host response in the 65 setting of uncomplicated disease, a finding to be further explored in future studies.
INTRODUCTION 67
Thrombocytopenia is the most common hematological alteration in malaria, 68 although there is no definitive mechanistic explanation to its occurrence (1, 2). In 69 a retrospective cohort, patients who died from malaria had lower platelet counts in 70 comparison to those with less severe disease (3). Moreover, P. vivax malaria 71 patients with thrombocytopenia showed higher levels of markers of endothelial 72 cell (EC) activation compared to those with normal platelet counts (4) and some 73 grade of platelet activation has been reported during the disease (5). Together, 74 these reports point out to a significant role of platelets in the pathophysiology of 75 malaria.
76
In cerebral malaria, the most severe presentation of the disease, platelets 77 have been shown to accumulate in the brain microvessels of affected children (6).
78
In mice, the adhesion of platelets to brain endothelial cells was crucial for the 79 development of the syndrome (7). In addition, platelets lead to a deleterious 80 inflammatory response in the disease through platelet-factor 4 (PF4), with PF4-81 KO mice surviving the infection (8). However, PF4 also plays a protective role in 82 the disease, as it mediates P. falciparum killing by platelets in vitro (9) and in vivo, 83 as shown in patients from Southeast Asia, and this was correlated with reduced 84 parasitemias (10).
85
EC activation is present in all malaria species, occurring in both mild and 86 severe cases (11). In terms of pathogenesis, EC activation is important for P. 87 falciparum-infected erythrocytes adhesion to microvasculature, avoiding 88 immunological clearance and leading to severe disease, while inducing more EC 89 damage (12). P. vivax-infected erythrocytes also adhere to EC (13), but the 90 magnitude of the phenomenon is smaller and if this has a role in endothelium 91 pathology and disease severity is not clear (14).
92
While the role of platelets in P. falciparum malaria has been extensively 93 studied, its role in the pathogenesis of EC dysfunction during P. vivax malaria 94 remains to be investigated. In this study, we show that platelet counts were reduced Platelet isolation and poor platelet plasma preparation 114 Whole blood was centrifuged at 180 g for 18 minutes at room temperature, 115 without brake for gradient formation, to obtain the platelet rich plasma (PRP). The
116
PRP was centrifuged at 100 g for 10 minutes for removal of residual leukocytes, 117 and subsequently centrifuged at 800g for 20 minutes to obtain the platelet pellet, 118 prostaglandin E1 300 nM was used to minimize platelet aggregation. The 119 supernatant of this centrifugation was centrifuged at 1000 g for 10 minutes to 120 obtain platelet poor plasma (PPP). and was inversely correlated with platelet counts in both patients and control 170 groups (Patients r= 0.4959, Controls r= 0.6898, both P<0.0001) ( Figure 1C ).
171
Platelet counts were not correlated with parasitemia. (Figure 2A-B were not different between the groups ( Figure 2C -E, Table 1 ). Patients' PPP failed 184 to activate platelets in comparison to PPP from controls ( Figure 2F ). with the markers of thrombopoiesis TPO and IL-11 and with ICAM-1 ( Figure 4B ).
202
Additionally, the heatmap generated from the expression of the analytes 203 revealed a defined separation of controls and two different groups of P. vivax 204 malaria patients ( Figure 4C ). In comparison to endemic control individuals one 205 group of P. vivax malaria patients had a lower overall variation in the response.
206
The second group of patients clearly showed a more potent response to the 207 infection, with a higher variation in the expression of platelet activation and EC 208 activation markers. Figure 4D -E displays the value of each pair of correlations. In the current study, we aimed to assess platelet activation and its 212 relationship with endothelial cell activation in the context of P. vivax malaria.
213
Thrombocytopenia was the most frequent hematological alteration in our cohort 214 and, as previously reported for malaria (1), was correlated to an increase in MPV.
215
Several disease states in which platelets are consumed mainly in the periphery 216 present with the same correlation. The slightly increased MPV in malaria patients 217 could be important during the disease as larger platelets are thought to be more 218 active in comparison to smaller ones, and have been implicated in diseases were endothelial activation and dysfunction play a central role (16). However, in this 220 study, MPV showed only a non-significant correlation with ICAM-1 levels.
221
Adding to the investigation of platelet disturbances during the disease, presented with uncomplicated malaria, we did not follow patients throughout their 279 illness to assess potential clinical implications of our findings.
280
In this study, we found evidence of platelet activation during vivax 281 malaria. Importantly, we show that soluble CD40L is elevated during the infection 282 and the positive associations with markers of EC activation indicate that this 283 molecule is a player in the pathogenesis of this disease. Therefore, we believe that 
